LncRNA MRPL39通过海绵吸附miR-130靶向PTEN调控人肺癌细胞的迁移和侵袭

被引:0
|
作者
范庆浩
鲍献荣
赵涵
机构
[1] 金华市人民医院心胸外科
关键词
非小细胞肺癌; 长链非编码RNA; MRPL39; miR-130; 侵袭;
D O I
10.19890/j.cnki.issn1674-6449.2023.05.013
中图分类号
R734.2 [肺肿瘤];
学科分类号
摘要
目的 探究LncRNA MRPL39对人非小细胞肺癌(non-small cell lung cancer, NSCLC)迁移和侵袭的影响及机制。方法 采用qPCR法检测肺癌及癌旁组织中MRPL39和miR-130的表达;构建低表达MRPL39的肺腺癌A549细胞株,CCK-8法、Transwell小室实验检测细胞增殖、迁移和侵袭,双荧光素酶报告基因验证MRPL39与miR-130靶向关系,并评价低表达MRPL39对裸鼠成瘤的影响。结果 与癌旁组织比较,肺癌组织中MRPL39升高,miR-130降低;与sh-NC组比较,sh-MRPL39组细胞中MRPL39、细胞存活率、N钙黏素和波形蛋白表达、移植瘤体积及重量明显降低,迁移细胞数和侵袭细胞数减少,E钙黏素表达升高;差异均有统计学意义(P<0.05)。双荧光素酶报告基因检测显示,MRPL39与miR-130存在靶向关系;干扰miR-130表达可部分逆转沉默MRPL39对细胞增殖、迁移和侵袭的影响,及上皮间质转化转移和第10号染色体丢失的磷酸酶基因(PTEN)表达的抑制作用。结论 敲低LncRNA MRPL39可抑制肺腺癌细胞增殖、迁移和侵袭能力,可能与海绵吸附miR-130调控PTEN表达有关。
引用
收藏
页码:545 / 549
页数:5
相关论文
共 13 条
  • [1] lncRNA HOXC-AS3吸附miR-216a-5p促进非小细胞肺癌细胞增殖和迁移的机制研究
    陈吉柏
    范长玲
    张浩
    [J]. 中国免疫学杂志, 2021, 37 (09) : 1082 - 1087+1093
  • [2] Lung Cancer: Epidemiology and Screening..[J].Oliver Aundrea L.The Surgical clinics of North America.2022, 3
  • [3] Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
    Nagasaka, Misako
    Uddin, Mohammed Hafiz
    Al-Hallak, Mohammed Najeeb
    Rahman, Sarah
    Balasubramanian, Suresh
    Sukari, Ammar
    Azmi, Asfar S.
    [J]. MOLECULAR CANCER, 2021, 20 (01)
  • [4] Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target
    Safi, Danish
    Abu Hejleh, Taher
    Furqan, Muhammad
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 462 - 474
  • [5] miR-130-3p Promotes MTX-Induced Immune Killing of Hepatocellular Carcinoma Cells by Targeting EPHB4..[J].Shao Liangtian;Ye Qing;Jia Moyang.Journal of healthcare engineering.2021,
  • [6] TMEM107 inhibits EMT and invasion of NSCLC through regulating the Hedgehog pathway..[J].Xu Huihui;Dun Song;Gao Ying;Ming Jian;Hui Linping;Qiu Xueshan.Thoracic cancer.2020, 1
  • [7] Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival
    She, Yunlang
    Jin, Zhuochen
    Wu, Junqi
    Deng, Jiajun
    Zhang, Lei
    Su, Hang
    Jiang, Gening
    Liu, Haipeng
    Xie, Dong
    Cao, Nan
    Ren, Yijiu
    Chen, Chang
    [J]. JAMA NETWORK OPEN, 2020, 3 (06)
  • [8] LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes..[J].Yang Wenhan;Qian Youhui;Gao Kaiping;Zheng Wenjing;Wu Guodong;He Qihan;Chen Qianqian;Song Yi;Wang Liang;Wang Yejun;Gu Peigui;Chen Bin;Zhai Rihong.Carcinogenesis.2020, 1
  • [9] Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
    Sun, Jie
    Zhang, Zicheng
    Bao, Siqi
    Yan, Congcong
    Hou, Ping
    Wu, Nan
    Su, Jianzhong
    Xu, Liangde
    Zhou, Meng
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [10] Long Noncoding RNA MRPL39 Inhibits Gastric Cancer Proliferation and Progression by Directly Targeting miR-130
    Yu, Ming Jun
    Zhao, Na
    Shen, Haibin
    Wang, Haiming
    [J]. GENETIC TESTING AND MOLECULAR BIOMARKERS, 2018, 22 (11) : 656 - 663